| Ruston L Stoltz, MD | |
|
4015 Gateway Blvd, Newburgh, IN 47630-8925 | |
| (812) 858-9400 | |
| (812) 858-9571 |
| Full Name | Ruston L Stoltz |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 28 Years |
| Location | 4015 Gateway Blvd, Newburgh, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023011418 | NPI | - | NPPES |
| 200103840 | Medicaid | IN | |
| 000000064811 | Other | IN | BCBS PIN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 01049215A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Deaconess Home Health, Llc | Evansville, IN | Home health agency |
| Deaconess Hospital Inc | Evansville, IN | Hospital |
| Women's Hospital The | Newburgh, IN | Hospital |
| Methodist Hospital | Henderson, KY | Hospital |
| Miller's Merry Manor | Rockport, IN | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Deaconess Clinic Inc | 3375610116 | 337 |
| Legacy Healthcare Services Inc | 2163339722 | 2654 |
News Archive
Epocal, Inc., a leading edge provider of point of care technology, announced today that it has received U.S. Food and Drug Administration (FDA) clearance to market its new glucose test on the epoc Blood Analysis System.
In a breakthrough in the understanding of how cancer does its deadly work, researchers at the University of Virginia School of Medicine have shown that many cancers - including nearly all pancreatic cancers - enslave and deform mitochondria, the powerhouses of cells, to create an environment more conducive to tumor growth.
Families with children suffering from brain tumours caused by an uncommon genetic disorder known as Tuberous Sclerosis Complex (TSC) have new hope with Health Canada's recent conditional approval of a new therapeutic use for the drug Afinitor (everolimus). Afinitor is the first drug therapy approved in Canada for the treatment of brain tumours caused by TSC in patients three years of age and older.
In the background, Republicans on Capitol Hill are renewing their criticisms of the health law's Independent Payment Advisory Board as a "rationing" panel. Also reverberating — how candidates are handling the GOP anti-abortion pledge, and findings from a new poll suggest Americans are leery of the Medicare plan advanced by Rep. Paul Ryan, R-Wis.
Senomyx, Inc., a company focused on using proprietary taste receptor-based technologies to discover novel flavor ingredients for the food, beverage, and ingredient supply industries, today provided a corporate update and reported financial results for the first quarter ended March 31, 2011.
› Verified 5 days ago
| Entity Name | Deaconess Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619123585 PECOS PAC ID: 3375610116 Enrollment ID: O20080922000145 |
News Archive
Epocal, Inc., a leading edge provider of point of care technology, announced today that it has received U.S. Food and Drug Administration (FDA) clearance to market its new glucose test on the epoc Blood Analysis System.
In a breakthrough in the understanding of how cancer does its deadly work, researchers at the University of Virginia School of Medicine have shown that many cancers - including nearly all pancreatic cancers - enslave and deform mitochondria, the powerhouses of cells, to create an environment more conducive to tumor growth.
Families with children suffering from brain tumours caused by an uncommon genetic disorder known as Tuberous Sclerosis Complex (TSC) have new hope with Health Canada's recent conditional approval of a new therapeutic use for the drug Afinitor (everolimus). Afinitor is the first drug therapy approved in Canada for the treatment of brain tumours caused by TSC in patients three years of age and older.
In the background, Republicans on Capitol Hill are renewing their criticisms of the health law's Independent Payment Advisory Board as a "rationing" panel. Also reverberating — how candidates are handling the GOP anti-abortion pledge, and findings from a new poll suggest Americans are leery of the Medicare plan advanced by Rep. Paul Ryan, R-Wis.
Senomyx, Inc., a company focused on using proprietary taste receptor-based technologies to discover novel flavor ingredients for the food, beverage, and ingredient supply industries, today provided a corporate update and reported financial results for the first quarter ended March 31, 2011.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ruston L Stoltz, MD Po Box 1510, Evansville, IN 47706-1510 Ph: (812) 858-9400 | Ruston L Stoltz, MD 4015 Gateway Blvd, Newburgh, IN 47630-8925 Ph: (812) 858-9400 |
News Archive
Epocal, Inc., a leading edge provider of point of care technology, announced today that it has received U.S. Food and Drug Administration (FDA) clearance to market its new glucose test on the epoc Blood Analysis System.
In a breakthrough in the understanding of how cancer does its deadly work, researchers at the University of Virginia School of Medicine have shown that many cancers - including nearly all pancreatic cancers - enslave and deform mitochondria, the powerhouses of cells, to create an environment more conducive to tumor growth.
Families with children suffering from brain tumours caused by an uncommon genetic disorder known as Tuberous Sclerosis Complex (TSC) have new hope with Health Canada's recent conditional approval of a new therapeutic use for the drug Afinitor (everolimus). Afinitor is the first drug therapy approved in Canada for the treatment of brain tumours caused by TSC in patients three years of age and older.
In the background, Republicans on Capitol Hill are renewing their criticisms of the health law's Independent Payment Advisory Board as a "rationing" panel. Also reverberating — how candidates are handling the GOP anti-abortion pledge, and findings from a new poll suggest Americans are leery of the Medicare plan advanced by Rep. Paul Ryan, R-Wis.
Senomyx, Inc., a company focused on using proprietary taste receptor-based technologies to discover novel flavor ingredients for the food, beverage, and ingredient supply industries, today provided a corporate update and reported financial results for the first quarter ended March 31, 2011.
› Verified 5 days ago
Gordon Brown, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4233 Gateway Blvd, Newburgh, IN 47630 Phone: 812-426-9700 Fax: 812-426-9701 | |
Renee Michelle Galen, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4233 Gateway Blvd, Newburgh, IN 47630 Phone: 812-426-9700 Fax: 812-426-9701 | |
Jon Scott Uloth, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 3711 Casey Rd, Newburgh, IN 47630 Phone: 812-490-1122 Fax: 812-490-1123 | |
Mrs. Carleen M Rubel, ACNP Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3799 Venetian Way, Newburgh, IN 47630 Phone: 812-471-4302 Fax: 812-471-4303 | |
Dr. Karen T Brake, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 100 St Marys Epworth Xing, Ste A300, Newburgh, IN 47630 Phone: 812-485-7752 Fax: 812-485-7753 | |
John Honnigford, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 10444 Sr 66, Newburgh, IN 47630 Phone: 812-853-9651 |